These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 16306248

  • 1. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA, Hermann B, La Rue A.
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [Abstract] [Full Text] [Related]

  • 2. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE, Bläsi S, Berres M, Monsch AU, Stähelin HB, Spiegel R.
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [Abstract] [Full Text] [Related]

  • 3. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 4. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Mar; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [Abstract] [Full Text] [Related]

  • 6. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.
    Rev Neurol; 2008 Apr; 38(9):801-7. PubMed ID: 15152345
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ, Rosnick CB, Fratiglioni L, Bäckman L.
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [Abstract] [Full Text] [Related]

  • 9. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L.
    Neurosci Lett; 2006 Mar 20; 396(1):23-7. PubMed ID: 16406347
    [Abstract] [Full Text] [Related]

  • 12. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA.
    Neurocase; 2005 Feb 20; 11(1):3-7. PubMed ID: 15804918
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F, Porcellini E, Caruso C, Lio D, Corder EH.
    Neurobiol Aging; 2007 Nov 20; 28(11):1637-43. PubMed ID: 16930778
    [Abstract] [Full Text] [Related]

  • 15. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.
    Arch Neurol; 2004 Dec 20; 61(12):1930-4. PubMed ID: 15596614
    [Abstract] [Full Text] [Related]

  • 16. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep 20; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH, Kim SY, Na HR, Kim BK, Yang DW, Kwon JC, Park MY.
    Dement Geriatr Cogn Disord; 2008 Sep 20; 25(5):445-50. PubMed ID: 18401173
    [Abstract] [Full Text] [Related]

  • 19. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G, van der Flier WM, de Langen C, Blankenstein MA, Scheltens P, Stam CJ.
    Clin Neurophysiol; 2008 Dec 20; 119(12):2727-32. PubMed ID: 18848805
    [Abstract] [Full Text] [Related]

  • 20. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H.
    Brain; 2008 May 20; 131(Pt 5):1252-8. PubMed ID: 18334538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.